Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency

References

• Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and physiological correlates: results of the Massachusetts Male Ageing Study. J Urol 1994; 151:54–61
   Google Scholar
• Fedele D, Bortolotti A, Coscelli C, Santeusanio F, Chatenoud L, Colli E, et al. Erectile dysfunction in type 1 and type 2 diabetics in Italy. Int J Epidemiol 2000;29:524–31
   Google Scholar
• Carlin BW. Impotence and diabetes. Metab Clin Exp 1988;37(Suppl 2): 19–21
   Google Scholar
• Kaiser FE, Korenman SG. Impotence in diabetic men. Am J Med 1988; 85:147–52
   Google Scholar
• Fedele D, Coscelli C, Santeusanio F, Bortolotti A, Chatenoud L, Colli E, et al. Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici. Diabetes Care 1998; 21:1973–7
   Google Scholar
• Popivanov P, Protich M, Manolov D, Velichkov P, Lazarov G. Autonomic neuropathy and erectile dysfunction in diabetic patients. Medicographia 1994;16(Suppl 1):94–5
   Google Scholar
• Dunsmuir WD, Holmes SA. The etiology and management of erectile, ejaculatory, and fertility problems in men with diabetes mellitus. Diabet Med 1996;13:700–8
   Google Scholar
• Andersson B, Mårin P, Lissner L, Vermeulen A, Bjorntorp P. Testosterone concentrations in women and men with NIDDM. Diabetes Care 1994;17:405–11
   Google Scholar
• Tibblin G, Alderberth A, Lindstedt G, Bjorntorp P. The pituitary-gonadal axis and health in elderly men: a study of men born in 1913. Diabetes 1996; 45:1605–9
   Google Scholar
• Fushimi H, Horie H, Inoue T, Kameyama M, Kanao K, Ishihara S, et al. Low testosterone levels in diabetic men and animals: a possible role in testicular impotence. Diabetes Res Clin Pract 1989; 6:297–301
   Google Scholar
• Morley JE, Perry HM III. Androgen deficiency in aging men. Med Clin North Am 1999;83:1279–89
   Google Scholar
• Morales A, Heaton JPW, Carson CC. Andropause: a misnomer for a true clinical entity. J Urol 2000; 163:705–12
   Google Scholar
• Reaven G. Role of insulin resistance in human disease. Diabetes 1988;37:1595–1607
   Google Scholar
• Zimmet P, Baba S. Central obesity, glucose intolerance and other cardiovascular disease risk factors: an old syndrome rediscovered. Diabetes Res Clin Pract 1990;10:S167–71
   Google Scholar
• Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-year cardio- vascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993; 16:434–44
   Google Scholar
• Haffner SM, Lehto S, Ronemaa T, Pyorala K, Laasko M. Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarc- tion. N Engl J Med 1998;339:229–43
   Google Scholar
• Kaplan N. The deadly quartet: upper body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Int Med 1989;149:1514–20
   Google Scholar
• Basaria S, Dobs AS. Risks versus benefits of testosterone therapy in elderly men. Drugs Aging 1999;15:131–42
   Google Scholar
• Mårin P, Krotkiewski M, Bjorntorp P. Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues. Eur J Med 1992;1:329–36
   Google Scholar
• Mårin P, Holmäng S, Jonsson L, Sjostrom L, Kvist H, Holm G, et al. The effects of testosterone treat- ment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord 1992;16:991–7
   Google Scholar
• Mårin P, Holmäng S, Gustafsson C, Bjorntorp P. Androgen treatment of abdominally obese men. Obes Res 1993;1:245–51
   Google Scholar
• Mårin P. Effects of androgens in men with the metabolic syndrome. Aging Male 1998;1:129–36
   Google Scholar
• Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11:319–26
   Google Scholar
• Ackerman MD, D’Attilio JP, Antoni MH, Campbell BM. Assessment of erectile dysfunction in diabetic men: the clinical relevance of self- reported sexual functioning. J Sex Marital Ther 1991;17:191–202
   Google Scholar
• Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999;54:346–51
   Google Scholar
• Rebuffe-Scrive M, Mårin P, Bjorntorp P. Effect of testosterone on abdominal adipose tissue in men. Int J Obes 1991;15:791–5
   Google Scholar
• Hislop MS, Ratanjee BD, Soule SG, Marais AD.Effects of anabolic-androgenic steroid use or gonadal testosterone suppression on serum leptin concentration in men. Eur J Endocrinol 1999;141:40–6
   Google Scholar
• Lund BC, Bever-Stille KA, Perry PJ. Testosterone and andropause: the feasibility of testosterone supplementation therapy in elderly men. Pharmaco- therapy 1999;19:961–6
   Google Scholar
• Glazer G. Atherogenic effects of anabolic steroid on serum lipid levels: a literature review. Arch Intern Med 1991;151:1925–33
   Google Scholar
• Kantor MA, Bianchini A, Bernier D, Sady SP, Thompson PD. Androgens reduce HDL2- cholesterol and increase hepatic triglyceride lipase activity. Med Sci Sports Exercise 1985;17:462–5
   Google Scholar
• Hromadova M, Haçik T, Malatinsky E, Sklovsky A, Cervenakov J, Labady F. Lipid metabolism in young males with hypotestosteronemia and oligospermia prior to, during and after treatment. Int Urol Nephrol 1991;23:69–75
   Google Scholar